Clinical Trials Directory

Trials / Completed

CompletedNCT01837446

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

Evaluating the Effectiveness of Topical Morphine Compared With a Routine Mouthwash in Managing Cancer Treatment-induced Mucositis in Patients With Head and Neck Cancer in Isfahan

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Oral mucositis is a debilitating side effects of cancer treatment for which there is not much successful treatments at yet. The investigators are going to evaluate the effectiveness of topical morphine compared with a routine mouthwash in managing cancer treatment-induced mucositis. The investigators hypothesize that topical morphine is more effective and more satisfied by patients than the magic mouthwash in reducing severity of cancer treatment-induced oral mucositis.

Conditions

Interventions

TypeNameDescription
DRUG2% morphine solution
DRUGMagnesium aluminum hydroxide
DRUG2% viscous lidocaine
DRUGDiphenhydramine

Timeline

Start date
2011-07-01
Primary completion
2012-07-01
Completion
2012-10-01
First posted
2013-04-23
Last updated
2013-04-23

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01837446. Inclusion in this directory is not an endorsement.